Subscribe | Stay Informed – Subscribe Today

Maxwell's Scotch McClure will give a presentation "Peptoids: The Future of Pharmaceutical Peptides" at the Drug Discovery Innovation Programme 2026 September 29-30 in Switzerland.

Read more →

Maxwell Biosciences’ Claromers Destroy Epstein-Barr

Maxwell Biosciences is part of a scientific revolution that sees a different story in the data. We believe that many of the most devastating brain diseases are not just failures of aging, but the result of a failed immune conversation. The brain is a fortress, but even the strongest walls need a modern defense.

Read more →

Rethinking the Resilient Brain: The New Frontier of Immuno-Neurology

Maxwell Biosciences is part of a scientific revolution that sees a different story in the data. We believe that many of the most devastating brain diseases are not just failures of aging, but the result of a failed immune conversation. The brain is a fortress, but even the strongest walls need a modern defense.

Read more →

Science

Featured

Screen-Shot-2020-05-05-at-8.26.06-AM.png

Maxwell Peptoids Active Against Herpes Simplex 1 (HSV-1)

Read more →

Next Generation Virucides – Peptoids

Read more →

Unless otherwise stated, the information on this website has not been evaluated by the Food & Drug Administration. As a research organization, we do not diagnose, treat, cure or prevent any illness or disease. Information is shared for educational purposes only. You must consult your doctor before acting on any content on this website, especially if you are pregnant, nursing, taking medication, or have a medical condition. Compounds in our clinical development programs are tested in animals in accordance with federal preclinical requirements. Compounds developed for cosmetics and personal care items are not tested on animals.